PharmaCyte Biotech Inc. | Income Statement
Fiscal year is May-April. All values USD Thousands.
2014
2015
2016
2017
2018
SG&A Expense
18,979.10
13,260.70
6,073.10
4,442.10
6,981.40
EBIT
18,979.10
-
6,073.10
4,442.20
6,981.40
Unusual Expense
2,359.90
-
-
-
-
Non Operating Income/Expense
5,895.00
3,338.00
10.50
-
152.60
Interest Expense
21.10
4.90
1.20
1.50
-
Pretax Income
27,254.00
9,927.70
6,063.80
4,443.70
6,828.80
Consolidated Net Income
27,254.00
9,927.70
6,063.80
4,443.70
6,828.80
Net Income
27,254.00
9,927.70
6,063.80
4,443.70
6,828.80
Net Income After Extraordinaries
27,254.00
9,927.70
6,063.80
4,443.70
6,828.80
Net Income Available to Common
27,254.00
9,927.70
6,063.80
4,443.70
6,828.80
EPS (Basic)
0.05
0.01
0.01
0.01
0.01
Basic Shares Outstanding
583,219.70
704,327.70
752,403.00
845,308.40
968,641.70
EPS (Diluted)
0.05
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
583,219.70
704,327.70
752,403.00
845,308.40
968,641.70
EBITDA
-
13,260.70
6,073.10
-
6,981.40
Non-Operating Interest Income
1.10
-
-
-
-
About PharmaCyte Biotech
View Profile
